Prospera Financial Services Portfolio holdings
Prospera Financial Services has been in business since 1982 and works as both an investment adviser and a brokerage. Prospera Financial, LLC owns it outright, and is itself majority owned and run, indirectly, by co-chief executives David Stringer and Tim Edwards and secretary Richard Pascuzzi. Its advisers offer clients its own Summit advisory programs and financial planning, plus programs from Envestnet, SEI and AssetMark, and most can also advise on insurance through its affiliate Prospera Life & Annuity.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$48.3M |
| 2 |
SpaceX
SPCX
|
+$43.1M |
| 3 |
Apple
AAPL
|
+$42.8M |
| 4 |
Listed Funds Trust Roundhill Magnificent Seven ETF
MAGS
|
+$32.5M |
| 5 |
Cisco
CSCO
|
+$24.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$36.9M |
| 2 |
Arm
ARM
|
+$25.2M |
| 3 |
AbbVie
ABBV
|
+$24.2M |
| 4 |
Western Digital
WDC
|
+$23.2M |
| 5 |
Intel
INTC
|
+$16.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.65% |
| 2 | Technology | 20.94% |
| 3 | Financials | 7.06% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Teva Pharmaceutical Industries Limited
TEVA
$49.5B
| $6.3M | 0.08% |
149,740
+14,322
| +11% | +$512K |
2019 Q2
29 quarters
|
|
277
Arthur J. Gallagher & Co
AJG
$72.5B
| $6.23M | 0.08% |
22,560
-279
| -1% | -$70K |
2019 Q1
30 quarters
|
|
278
iShares Core S&P Total US Stock Market ETF
ITOT
$95.1B
| $6.21M | 0.08% |
37,626
+1,988
| +6% | +$331K |
2019 Q2
29 quarters
|
|
279
Mondelez International
MDLZ
$84.2B
| $6.2M | 0.08% |
95,522
+76,081
| +391% | +$4.68M |
2013 Q2
53 quarters
|
|
280
First Trust Growth Strength ETF
FTGS
$1.28B
| $6.2M | 0.08% |
165,416
+9,033
| +6% | +$348K |
2024 Q2
9 quarters
|
|
281
FedEx
FDX
$74.8B
| $6.2M | 0.08% |
19,773
+1,480
| +8% | +$465K |
2020 Q1
26 quarters
|
|
282
Vanguard FTSE Emerging Markets ETF
VWO
$120B
| $6.17M | 0.08% |
111,196
+52,431
| +89% | +$3.13M |
2020 Q3
24 quarters
|
|
283
Williams Companies
WMB
$84.3B
| $6.17M | 0.08% |
83,004
+30,376
| +58% | +$2.21M |
2022 Q1
18 quarters
|
|
284
State Street Industrial Select Sector SPDR ETF
XLI
$30.9B
| $6.13M | 0.08% |
36,591
-2,761
| -7% | -$492K |
2015 Q4
43 quarters
|
|
285
Best Buy
BBY
$21.8B
| $6.13M | 0.08% |
+64,054
| New | +$5.53M |
2026 Q3
0 quarters
|
|
286
Vertiv
VRT
$74.8B
| $6.1M | 0.08% |
26,218
+8,636
| +49% | +$2.35M |
2024 Q2
9 quarters
|
|
287
iShares National Muni Bond ETF
MUB
$54.9B
| $6.07M | 0.08% |
58,303
-2,925
| -5% | -$307K |
2019 Q2
29 quarters
|
|
288
Broadridge
BR
$21.8B
| $6.05M | 0.08% |
33,820
+23,521
| +228% | +$3.84M |
2019 Q4
27 quarters
|
|
289
HCA Healthcare
HCA
$105B
| $6.02M | 0.08% |
12,723
+227
| +2% | +$93K |
2023 Q2
13 quarters
|
|
290
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $6.01M | 0.08% |
86,593
+10,239
| +13% | +$735K |
2013 Q2
53 quarters
|
|
291
IQVIA
IQV
$45.3B
| $6.01M | 0.08% |
22,499
+16,794
| +294% | +$4.06M |
2024 Q3
8 quarters
|
|
292
Capital Group Global Growth Equity ETF
CGGO
$11.8B
| $6.01M | 0.08% |
160,432
+15,547
| +11% | +$625K |
2022 Q4
15 quarters
|
|
293
Stanley Black & Decker
SWK
$17.3B
| $5.89M | 0.08% |
+56,932
| New | +$5.35M |
2026 Q3
0 quarters
|
|
294
First Trust AAA CMBS ETF
CAAA
$34.8M
| $5.88M | 0.08% |
295,417
-499
| -0.2% | -$10K |
2025 Q2
5 quarters
|
|
295
Vanguard FTSE Europe ETF
VGK
$30.3B
| $5.87M | 0.08% |
67,017
+57,597
| +611% | +$5.19M |
2025 Q1
6 quarters
|
|
296
Vanguard Intermediate-Term Bond ETF
BIV
$28.7B
| $5.79M | 0.07% |
77,783
-27,721
| -26% | -$2.08M |
2019 Q2
29 quarters
|
|
297
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.15B
| $5.78M | 0.07% |
19,733
+8,253
| +72% | +$2.58M |
2016 Q4
39 quarters
|
|
298
Ecolab
ECL
$85.8B
| $5.76M | 0.07% |
19,023
+11,091
| +140% | +$3.08M |
2015 Q4
43 quarters
|
|
299
Charles Schwab
SCHW
$161B
| $5.75M | 0.07% |
65,335
+14,041
| +27% | +$1.48M |
2020 Q3
24 quarters
|
|
300
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
$3.49B
| $5.65M | 0.07% |
109,372
+6,925
| +7% | +$352K |
2023 Q3
12 quarters
|
|
Similar funds
Prospera Financial Services's Q3 2026 Portfolio in Review
As of Q3 2026, Prospera Financial Services held 1,651 positions worth $7.73B, up 12% from $6.89B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Prospera Financial Services deployed $900M of net new capital in Q3 2026, opening 183 new positions and adding to 799 existing holdings. Its largest new stake was iShares US Pharmaceuticals ETF: 130,953 shares worth $14.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, down from 43% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $36.9M trimmed.
- Prospera Financial Services's largest Q3 2026 buy was iShares US Pharmaceuticals ETF: 130,953 shares worth $14.1M.
- Prospera Financial Services added most to NVIDIA in Q3 2026, an estimated $48.3M increase.
- Prospera Financial Services's biggest Q3 2026 reduction was iShares Russell 1000 Value ETF, cutting an estimated $36.9M.
- Prospera Financial Services fully exited AbbVie in Q3 2026, selling an estimated $24.2M.
- Prospera Financial Services's ten largest holdings make up 19% of its $7.73B portfolio in Q3 2026.
- Prospera Financial Services opened 183 new positions and closed 140 in Q3 2026.
- Prospera Financial Services's portfolio value rose 12% quarter-over-quarter to $7.73B.
Based on Prospera Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.